Background The potential benefit of implantable cardioverter-defibrillator (ICD) therapy in
individuals with inherited arrhythmia syndromes is well known. However, it is not deprived of …

Objectives Brugada syndrome (BrS) is an ion channelopathy that predisposes affected
patients to spontaneous ventricular tachycardia/fibrillation (VT/VF) and sudden cardiac …

Understanding health care resource utilisation and its associated costs are important for
identifying areas of improvement regarding resource allocations. However, there is limited …

Introduction: Congenital long QT syndrome (LQTS) is a cardiac ion channelopathy that
predisposes affected individuals to spontaneous ventricular tachycardia/fibrillation (VT/VF) …

Background A combination of clinical and electrocardiographic risk factors is used for risk
stratification in Brugada syndrome. In this study, we tested the hypothesis that the …

No real-world data are available about the complications rate in drug-induced type 1
Brugada Syndrome (BrS) patients with an implantable cardioverter-defibrillator (ICD). Aim of …

Background The aim of this study is to report on the genetic composition of Brugada
syndrome (BrS) patients undergoing genetic testing in Hong Kong. Methods Patients with …

Abstract Introduction Most patients with Brugada syndrome (BrS) are first diagnosed in their
40s, with sudden cardiac death (SCD) often occurring in their 50s. Ventricular fibrillation (VF) …

Introduction Patients with Brugada electrocardiographic (ECG) patterns have differing levels
of arrhythmic risk. We hypothesized that temporal variations in certain ECG markers may …

Cardiac ion channelopathies encompass a set of inherited or acquired conditions that are
due to dysfunction in ion channels or their associated proteins, typically in the presence of …